Covered recipient · General Payments record
KIMBERLY DAO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$341.86
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $341.86 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $78.94 | 5 |
| Lilly USA, LLC | $73.65 | 3 |
| Acerta Pharma LLC | $35.40 | 2 |
| Phathom Pharmaceuticals, Inc. | $35.25 | 1 |
| Dynavax Technologies Corporation | $26.99 | 1 |
| Amgen Inc. | $21.49 | 1 |
| Novo Nordisk AS | $21.11 | 1 |
| Janssen Pharmaceuticals, Inc | $19.11 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.57 | 1 |
| ABBVIE INC. | $14.35 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $341.86 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.35 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103600414 | CMS |
| Amgen Inc. | $21.49 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111558417 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.57 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104539390 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.83 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104380153 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.57 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086210821 | CMS |
| Dynavax Technologies Corporation | $26.99 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082153853 | CMS |
| Janssen Pharmaceuticals, Inc | $19.11 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077977350 | CMS |
| Lilly USA, LLC | $22.63 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135107519 | CMS |
| Lilly USA, LLC | $25.64 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135114596 | CMS |
| Lilly USA, LLC | $25.38 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135112534 | CMS |
| Novo Nordisk Inc | $21.11 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097242371 | CMS |
| PFIZER INC. | $15.26 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131833252 | CMS |
| PFIZER INC. | $14.78 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131863743 | CMS |
| PFIZER INC. | $17.30 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131833224 | CMS |
| PFIZER INC. | $14.14 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131132118 | CMS |
| PFIZER INC. | $17.46 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131420680 | CMS |
| Phathom Pharmaceuticals, Inc. | $35.25 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151053619 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.